| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 131 |
| 1 | AGALSIDASE BETA | 66 |
| 2 | INTERFERON BETA-1A | 65 |
| 3 | ERGOCALCIFEROL | 22 |
| 4 | INTERFERON BETA-1B | 20 |
| 5 | METRELEPTIN | 19 |
| 6 | ROMIPLOSTIM | 18 |
| 7 | ERYTHROPOIETIN | 17 |
| 8 | ACETAMINOPHEN | 15 |
| 9 | RIBAVIRIN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAMLINTIDE ACETATE | 2 | 0.0196 |
| 1 | METRELEPTIN | 19 | 0.0150 |
| 2 | AGALSIDASE BETA | 66 | 0.0071 |
| 3 | AVALGLUCOSIDASE ALFA-NGPT | 5 | 0.0050 |
| 4 | BACTERIOSTATIC WATER | 2 | 0.0048 |
| 5 | RIMABOTULINUMTOXINB | 1 | 0.0030 |
| 6 | CORTISOL | 1 | 0.0025 |
| 7 | CALASPARGASE PEGOL | 2 | 0.0025 |
| 8 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 9 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 131 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 66 |
| 2 | Interferon beta [EPC] | 66 |
| 3 | Provitamin D2 Compound [EPC] | 22 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 5 | Leptin Analog [EPC] | 19 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 18 |
| 7 | Corticosteroid [EPC] | 17 |
| 8 | Insulin Analog [EPC] | 17 |
| 9 | Vitamin C [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 19 | 0.0150 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 66 | 0.0068 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 7 | 0.0020 |
| 3 | Integrin Receptor Antagonist [EPC] | 131 | 0.0015 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 18 | 0.0012 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 9 | 0.0009 |
| 6 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 7 | Glucosylceramide Synthase Inhibitor [EPC] | 2 | 0.0007 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 6 | 0.0004 |
| 9 | Asparagine-specific Enzyme [EPC] | 6 | 0.0004 |